Is There a Blood Test to Rule Out Psoriasis?
No, there is no blood test that can rule out psoriasis—the diagnosis is made clinically based on patient history and physical examination findings, with skin biopsy used selectively when the diagnosis is uncertain. 1
Diagnostic Approach to Psoriasis
Clinical Diagnosis is the Gold Standard
- Psoriasis is diagnosed primarily through clinical examination, looking for characteristic erythematous, inflammatory patches and plaques with silvery scale, often on extensor surfaces like elbows and knees 1
- Patient and family history of psoriasis strongly supports the diagnosis, as psoriasis has significant genetic predisposing factors 1, 2
- Skin biopsy is reserved for atypical presentations or when psoriasis does not respond appropriately to therapy, particularly to rule out cutaneous T-cell lymphoma 1
Blood Tests Are Used for Different Purposes
Blood tests in psoriasis serve three distinct roles, but none can diagnose or exclude psoriasis:
1. Ruling Out Differential Diagnoses
- HIV screening can be useful when erythroderma is present, as HIV may present similarly 1
- Flow cytometry and Sézary cell count help assess for cutaneous T-cell lymphoma or Sézary syndrome when atypical lymphocytes are suspected 1
- T-cell receptor gene rearrangement clonality testing can help differentiate psoriasis from cutaneous T-cell lymphoma in difficult cases 1
2. Screening for Comorbidities
- Fasting lipid panels, fasting glucose, and other cardiovascular risk markers are recommended for screening psoriasis-associated comorbidities, not for diagnosing psoriasis itself 1
- Renal function testing may be indicated given the association between severe psoriasis and chronic kidney disease 1, 3
3. Monitoring Treatment Safety
- Baseline and monitoring laboratory tests (CBC, liver function, renal function) are used when initiating systemic therapies like methotrexate or biologics, but these do not diagnose psoriasis 1, 4
Research on Serum Biomarkers
While research has identified elevated inflammatory markers in psoriasis patients, these are not clinically useful for diagnosis:
- Elevated IL-6, CRP, TNF-α, E-selectin, and ICAM-1 have been documented in psoriasis patients compared to controls, but with significant overlap that precludes diagnostic utility 5
- Serum biomarkers using ELISA are being investigated for severity assessment and therapeutic monitoring, but remain research tools rather than diagnostic tests 6
- The modest elevation of inflammatory markers (standardized mean differences of 1.3-1.8) is not specific enough to distinguish psoriasis from other inflammatory conditions 5
Key Clinical Pitfalls to Avoid
- Do not delay diagnosis waiting for laboratory confirmation—psoriasis is a clinical diagnosis and treatment should not be postponed for unnecessary testing 1, 7
- Beware of erythrodermic psoriasis mimics: atopic dermatitis, contact dermatitis, cutaneous T-cell lymphoma, and pityriasis rubra pilaris can appear similar both clinically and histologically 1
- Look for subtle diagnostic clues: areas of indurated plaques with silvery scale, nail pitting, lack of "skip areas" in erythroderma, and absence of significant palmoplantar keratoderma favor psoriasis over other diagnoses 1
- Consider biopsy when presentations are atypical, particularly for groin or buttock lesions that could represent cutaneous T-cell lymphoma 1
Practical Clinical Algorithm
When evaluating suspected psoriasis:
- Obtain detailed personal and family history of psoriasis or other immune-mediated diseases 1, 2
- Perform thorough skin examination looking for characteristic plaques, distribution patterns, and nail changes 1, 8
- If diagnosis is clear clinically, proceed with treatment without laboratory testing 1
- If presentation is atypical or diagnosis uncertain, obtain skin biopsy—but recognize that histology can also be variable and non-specific 7
- Use blood tests only to exclude mimics (HIV, lymphoma) or screen for comorbidities, never to "rule out" psoriasis 1